Effect of maprotiline, a new antidepressant drug, on serotonin uptake.
D000328:Adult; D000818:Animals; D000873:Anthracenes / Q000494:pharmacology*; D000928:Antidepressive Agents / Q000494:pharmacology*; D001792:Blood Platelets / Q000378:metabolism; D001923:Brain Chemistry / Q000187:drug effects; D001952:Bridged-Ring Compounds / Q000494:pharmacology; D003864:Depression, Chemical; D003891:Desipramine / Q000494:pharmacology; D004027:Diencephalon / Q000378:metabolism; D005260:Female; D005470:Fluorometry; D006801:Humans; D007099:Imipramine / Q000494:pharmacology; D008636:Mesencephalon / Q000166:cytology; D009638:Norepinephrine / Q000378:metabolism; D010627:Phenethylamines / Q000494:pharmacology; D011437:Propylamines / Q000494:pharmacology; D051381:Rats; D012701:Serotonin / Q000097:blood / Q000378:metabolism*; D013574:Synaptosomes / Q000378:metabolism; D013997:Time Factors; D014316:Tritium
D000873:Anthracenes; D000928:Antidepressive Agents; D001952:Bridged-Ring Compounds; D010627:Phenethylamines; D011437:Propylamines; D014316:Tritium; D012701:Serotonin; D007099:Imipramine; D003891:Desipramine; D009638:Norepinephrine